Caesars Entertainment bets £2.9bn on William Hill takeover
The board of British bookmaker William Hill has recommended a takeover bid from US gaming giant Caesars Entertainment. Matthew Partridge reports


William Hill is heading to the US. The UK bookmaker’s board has recommended a £2.9bn cash offer from America’s Caesars Entertainment, one of its largest gaming groups; its properties include the famous Caesars Palace hotel and casino in Las Vegas. At 272p a share, this offer represents a premium of 60% to William Hill’s share price before Caesars first approached it in early September and is well over double the 128p at which William Hill raised money from shareholders a few months ago. Caesars is funding the purchase by issuing shares of its own. The deal will be put to William Hill’s shareholders at the company’s next general meeting.
Caesars isn’t the only company interested in buying William Hill; the other potential suitor is buyout firm Apollo Global Management, which could still launch a counterbid. But it has been “unceremoniously lapped” by the “lightning speed” of talks between Caesars and William Hill, as Ben Marlow puts it in The Daily Telegraph. And Caesars’ “bombshell” announcement that it would end its current US joint venture tie up with William Hill if anyone else bought the UK group also militates against a takeover by Apollo.
The American market is the main prize
Caesars’ threat to end the joint venture if William Hill was bought by anyone else has been pivotal: the “promising” US division of William Hill is the part that “everyone wants”, says Nils Pratley in The Guardian. While the US sports betting market is growing, helped by a gradual loosening of America’s laws around online gambling, the UK market is a “mess” owing to the industry’s “fixation” with fixed-odds betting terminals, which are facing further regulatory crackdowns. Overall, Caesars’ control over the joint venture seems to have made it “impossible” for William Hill to escape its clutches.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Caesars now looks set to “end up with a lot more chips than it is putting down”, says Stephen Wilmot in The Wall Street Journal. This is because enthusiasm about the potential for online gambling in the US is so strong that rival sports-betting firm DraftKings is commanding a valuation “reniscent of the software sector”. If this continues Caesars could make a lot of money by selling off the UK betting shops, building up the US business and then spinning off the online operations as a separate company.
Given the strong prospects for the US market, William Hill’s shareholders could always decide to reject the offer for now, hoping that the revenues from the US operations will further enhance the bookmaker’s value, says Kate Burgess in The Guardian. Some experts think its share of the joint venture is worth at least £3bn, which would mean the overall firm should be worth £1bn more than Caesars is offering. But this is a risky option as its US operations “won’t make a profit for at least three years”, forcing it to “spend many millions on branding”.
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge
-
Why stagflation now seems like America's "optimistic scenario"
Investors have gone into tariff shock, and stagflation could now be the optimistic scenario for the US economy.
By Alex Rankine
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves
-
India's stock market decline wipes out $1.3 trillion in market value – can investors stay optimistic?
More than $1 trillion has been wiped off from India's stock market after investors turn to China. Has the emerging-market darling hit rock bottom?
By Alex Rankine
-
Pensions revolution: how to profit from the trends shaping the UK pension system
The UK pension system is one of the biggest in the world. Big changes are under way, says Rupert Hargreaves
By Rupert Hargreaves